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Summary 
Neural-restrictive silencer (NRS) has well been characterized in SCG10 and many 
other neuron-specific genes; it is, however, unknown whether the promoters of the 
SCLIP and RB3 genes (two other SCG10 family members) share basal transcriptional 
mechanisms with SCG10 or not. To explore how NRS-mediated neural-specific gene 
transcription has evolved, we determined the genomic and promoter structures of the 
SCLIP gene, and found that the gene retained an NRS-like element that functioned as 
a negative regulator in non-neuronal cells. However, unlike the NRS in the SCG10 
gene, this NRSSCLIP was located downstream of the transcription start site, and 
showed a position-dependent repressing activity. Further gel-shift and NRS factor 
(NRSF) co-transfection experiments revealed that NRSSCLIP was bound and regulated 
by NRSF. Such an element was not found in the gene promoter of RB3, suggesting 
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Introduction 
Transcriptional mechanisms for cell-type specific gene expression generally 
involve both positive and negative regulatory factors, which recruit either co-activator 
or co-repressor that binds to histone modifying proteins such as acetylases or 
deacetylase, thereby leading to chromatin remodeling (1). The chromatin structural 
modification triggers and stabilizes cellular differentiation status; thus the enhancer or 
silencer-mediated chromatin remodeling is a central mechanism of cellular 
specification during animal development (2).  
During the mammalian nervous system development a cell-type selective 
negative regulator named NRSF (neural-restrictive silencing factor) (3) or REST 
(Repressor element-1 silencing transcription factor) (4) plays pivotal role in 
determining neuron-specific gene expression (5-8). The transcriptional regulation by 
NRSF/REST is a key issue during neuronal differentiation, maturation, plasticity, 
diseases, as well as stem cell maintenance (9-15). The target sequence of NRSF/REST 
is a 22 base pair-long neural restrictive silencer element (NRSE) (also called RE-1), a 
versatile negative-acting cis regulatory element that prevents the expression of 
neuron-specific genes in non-neuronal cells (16-18). While the genome data survey 
studies of NRSE demonstrate that the total numbers of potential target genes of the 
NRSF/REST in the human genome exceed 1,000 genes (19-21), its exact biochemical 
analyses of the cell-type specific promoter repression by this factor has been 
elucidated for a limited set of genes including neuronal growth-associated proteins, 
ion channels, neuropeptides, neurotransmitter synthetic enzymes, neurotransmitter 
receptors, neurotrophins, and their receptors (22-37; also see reviews 38,39 and 
references their in).  
The transcription factor binding to NRS, i. e., NRSF/REST, is a bipartite 
repressor possessing two distinct repression domains near the N-terminus and at the 
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C-terminus. The transcriptional repression mechanisms via these two repression 
domains, i.e. RD-1 and RD-2, have been resolved: RD-1 recruits co-repressor mSin3 
and histone deacetylase (HDAC) (40-44); whereas RD-2 binds CoREST and N-CoR 
(45-49). NRSF/REST also interacts with ATP-dependent chromatin remodeling 
SWI/SNF complex, or even basal transcriptional factor such as TATA-binding protein 
(TBP) (50,51). While the overall mechanisms of NRSF/REST-dependent 
transcriptional regulation for cell-type specificity and other circumstances still remain 
to be elucidated,, the NRS-NRSF system is now well recognized to be a fundamental 
basis of the neuron-specific gene regulation in developing and mature neurons.  
Although the transcriptional regulatory mechanism via NRS and NRSF is well 
understood with respect to SCG10 (superior cervical ganglia clone No.10) 
(3,16,17,41,52), the mechanism of cell-type specific transcriptional regulation of other 
members of the SCG10 gene family (53-57) remains unclear. While SCG10 seems 
evolved by gene duplication of the prototypic stathmin gene, evidence suggests that 
SCLIP (58) and RB3 (59), two additional members of the SCG10/stathmin family, are 
also expressed in neurons. Particularly, SCLIP is highly expressed in fully developed 
pyramidal cells and Purkinje cells, and retinal ganglion cells of the adult brain (60,61). 
Unlike SCG10, SCLIP inhibits neurite outgrowth and promotes axonal branching 
(62,63). SCLIP is highly expressed in mature neurons, but there is some evidence 
suggesting that SCLIP is also expressed in some non-neural tissues (64,65).  
To examine the factors regulating the neural-preferred transcriptional 
regulation of SCLIP and RB3, we isolated genomic clones containing the 5' 
transcription regulatory region of these genes. The present study explored the 
molecular mechanisms underlying SCLIP gene expression, focusing on potential roles 
of NRS or NRS-like element. We identified an NRS-like sequence (NRSSCLIP) in the 
translation starting point in exon 1 of the SCLIP gene and showed that it was critical 
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for the neuronal expression of the SCLIP gene. This NRSSCLIP element functioned as a 
cell-selective repressor wherever it was located around the SCLIP promoter; however, 
the level of this repressing effect varied depending upon the position relative to the 
promoter. 
 
Materials and Methods 
Library screening and determination of genomic structure 
A 129 SVJ Mouse Genomic Library (Stratagene, La Jolla, CA, USA) was 
screened with (-32P) dCTP-labeled mouse SCLIP and RB3 cDNA probes that had 
been generated by reverse transcription followed by the polymerase chain reaction 
(RT-PCR) using primers based on the published sequence. Inserts of three 
independent positive lambda phage clones of the SCLIP gene were subcloned into 
pBluescript II SK (-) at a NotI site, and were termed pmgSCLIP-1, 2 and 3. Four 
positive phage clones of the RB3 gene were also cloned, and their inserts were 
subcloned into the same vector, and named pmgRB3-1, 2, 3, and 4. Nucleotide 
sequencing was performed by the use of ABI PRISM 377 (Applied Biosystems). To 
determine the exon-intron boundaries, we compared the genomic sequences with the 
cDNA sequences of mouse SCLIP and RB3 (GenBank/EMBL/DDBJ: accession nos. 
AF069708 and AF105222).  
Primer extension assay 
Primer extension was performed as described previously (16) using an 
inverted sequence of NRSSCLIP-containing oligonucleotide (see below) with Neuro2a 
RNA as a template. Extension products were separated on a 10% denaturing 
polyacrylamide gel with a 32P-labeled size marker of Hinf-I digests of X174 DNA. 
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Plasmid construction 
The 5’ upstream fragments (4.7 kb and 1.0 kb) starting from the first 
methionine codon of pmgSCLIP-3 were subcloned into the luciferase reporter plasmid 
pGL3-Basic vector (Promega) at XhoI and NcoI sites (Luc-SL470) and HindIII and 
NcoI sites (Luc-SL101), respectively. A series of deletion mutants (Luc-SL358, 
Luc-SL157, Luc-SL35, Luc-SL23, Luc-SL13, and Luc-SL5) were generated by 
digesting the Luc-SL470 with a deletion kit (TaKaRa); and Luc-dp(-) was made by 
deleting the 370-bp NcoI fragment of Luc-SL101. These constructs were devoid of 
NRSSCLIP due to the ligation to the luciferase sequence in the middle of the NRS 
element. For reconstitution of the NRSSCLIP sequence in the SCLIP-luciferase 
plasmids, Luc-NSL23, containing NRSSCLIP, was generated by altering Luc-SL23 
with an oligonucleotide (5'-GGTGCTGGCCATGGTGCTGGC-3') according to the 
Kunkel method as described previously (41). A single NRSSCLIP element of 
self-complementary oligonucleotide pairs (5'-CGCCAGCACCATGGCCAGCACCG 
GTAC-3' and 5'-CGGTGCTGGCCATGGTG CTGGCGGTAC-3') was inserted at the 
most 5' region of Luc-SL157, Luc-SL101, Luc-SL35, and Luc-SL23 at a KpnI site to 
generate a series of NRSSCLIP-containing constructs (Luc-NSL157, Luc-NSL101, 
Luc-NSL35, and Luc-NSL23). 
Transfection and reporter gene assay 
RAT1, PC12, NIH-3T3, and Neuro2a cells were maintained and transfected 
with the aforementioned luciferase-expression plasmids driven by the SCLIP 
promoter by using Lipofectamine Plus (GIBCO/BRL), as described previously 
(41,52). For luciferase assays, 5-8 x 104 RAT1 or PC12 cells in a 24-well plate were 
transfected with about 200ng (0.06pmol equivalent) of luciferase reporter plasmid and 
50 ng of control Renilla luciferase vector (pRL-TK) (Promega), the latter used as an 
internal control for transfection efficiency. pBluescriptII SK(-) was used as a carrier 
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to bring the total amounts of plasmids to 300 ng. Cellular extracts were prepared 48 hr 
after transfection, and dual-luciferase activities were measured with a luminometer 
(Lummat LB96V; EG&G, Salem, MA). All transfection experiments were performed 
three times, and averages and SEs of the luciferase activities of three independent 
experiments, each conducted with triplicate dishes, were calculated. 
Electrophoretic mobility shift assay 
Nuclear extracts were prepared from RAT1 and PC12 cells as described 
previously (41,52). Self-complementary oligonucleotide pairs were labeled with  
(-32P) dCTP by use of a Megaprime DNA labeling kit (Pharmacia) and purified 
with a QIAquick Gel Extraction Kit 250 (QIAGEN). The oligonucleotides for the gel 
shift assays were as follow: for the SCLIP NRS, 
5'-AGCCGCCGCCAGCACCATGGCCAGCACC-3' and 
5'-AGATACGGTGCTGGCC ATGGTGCTGGC-3'; and for the SCG10 NRS, 
5'-AAGCCATTTCAGCACCACGG AGAGTGCC-3' and 
5'-AGCAGAGGCACTCTCCGTGGTGCTGAA-3'. For DNA binding assays, 5 g of 
nuclear extract was incubated at room temperature for 20 min with 50,000 cpm of the 
labeled probes, 4 l of 5X binding buffer (50 mM HEPES (pH 7.9), 250 mM KCl, 25 
mM MgCl2, 50% Glycerol, 25 mM DTT, 3.5 mM PMSF, 250 M ZnCl2), and 1 g of 
poly(dI-dC) in a total volume of 20 l. For supershift experiments, monoclonal 
antibody raised against NRSF (3B7) was used, as described previously (33). The 
binding reaction mixtures were electrophoresed at 10 mA for 90 min at 4˚C on a 4% 
polyacrylamide gel in modified 0.25X TEA (40mM Tris-HCl pH7.8, 37mM sodium 
acetate) containing 2.5% glycerol. The gels were dried and exposed to an X-ray film 
with an intensifying screen at -80℃. 
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Results 
Homology of the genomic organization of the SCLIP gene with that of other 
members of the SCG10 gene family 
The mouse SCLIP gene was obtained by screening a liver genomic DNA 
library. The full-length SCLIP gene corresponding to the 5 coding exons was 
determined, and the genomic organization is presented in Fig.1. Although the first 
intron sequence was not fully determined, the total size of the mouse SCLIP gene was 
estimated to be approximately 11 kb based on restriction digests (see Fig. 1A). The 
genome sequence was compared with the previously published cDNA sequence 
(54,58) in order to determine the exon-intron boundaries (Fig. 1B). We also screened 
for the mouse RB3 gene, and found that it spanned 7 kb of genomic DNA and was 
also composed of 5 coding exons with 567 bp of ORF covering the initiation 
methionine to the stop codon. Its genomic and cDNA sequences were likewise 
compared to determine exon-intron boundaries. Beside the 5 conserved exon/intron 
boundaries, 2 additional donor/acceptor sites for splicing were also found between 
exons 2 and 3 and between exons 4 and 5 in the mouse RB3 gene, which presumably 
give rise to the alternative splicing forms known as RB3’ and RB3’’, respectively 
(54,56).  
As previously reported (53), the total size of the SCG10 gene was quite 
different from that of the stathmin gene, even though the 2 genes shared a similar 
exon-intron structure. When the relative distances among these exons of SCG10 and 
the 3 SCG10-related genes were compared, it become clear that exons 2 and 3 were 
located relatively close to each other in all family member, as were exons 4 and 5, 
except in the case of the RB3 gene (Fig. 1C). As aforementioned, the RB3 gene 
contained 2 additional exons, 2’ and 4’, used for alternative splicing. Comparison of 
the mouse amino acid sequences of each of the major coding exons of the SCG10 
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family members is presented in Fig. 1D. The homology in the mouse amino acid 
sequences and exon organization clearly demonstrate that all SCG10 family members 
were generated by gene duplication, which is consistent with the previous notion 
obtained from the comparison of rat RB3 and mouse SCLIP genes (58). 
Distinct promoter feature of the SCLIP gene 
Although the exon organization was conserved among the SCG10 family 
members, the promoter upstream sequence of the mouse SCLIP gene, at least up to 
2.0 kb in length, was unrelated to that of neither SCG10 or RB3 genes (by FASTA 
alignment, data not shown). Even though SCLIP gene transcripts could be detected in 
some non-neural tissues in human (64), the expression of both SCG10 and SCLIP 
genes is known to be highly abundant in neurons (58,61). We then compared the 
5’upstream of the mouse SCLIP gene with that of the human SCLIP gene deposited in 
GenBank (accession number AF217796) including the first exon, and found that there 
was a high degree of similarity in the proximal region of the promoter between mouse 
and human SCLIP genes (Fig. 2A). The sequence of the first exon and splice junction 
were highly conserved, and the proximal promoter regions contained putative binding 
sites for transcriptional factors SP1 and TFII-I (Fig. 2A). However, further upstream 
sequence, at least for 2.0 kb, revealed little homology between the two species. To 
determine the transcriptional start sites of the mouse SCLIP gene, we performed a 
primary extension assay with Neuro2a cell-derived RNA as a template (Fig. 2B). 
There were at least six primary extension products suggesting that there may exist 
multiple transcriptional initiation sites (see Fig. 2A). We conclude that this region 
contains the promoter of the mouse SCLIP gene. The mouse sequence was deposited 
to GenBank through DDBJ/SAKURA with the entry ID number: 
20010723133031.31621. 
To examine whether the DNA sequence upstream of exon 1 in the mouse 
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SCLIP gene had promoter activity, we prepared a series of deletion constructs 
containing the first methionine codon along with various lengths of the 5' flanking 
sequence from the mouse SCLIP gene, and examined their activity in both neural 
(PC12) and non-neural (RAT1) cells. The six longer constructs containing as few as 
240 bp and as many as 4700 bp upstream from the first methionine showed significant 
promoter activity (Fig. 2B). Luc-SL23 was the most active promoter construct in 
PC12 and RAT1 cells; however, further deletion resulted in a dramatic reduction of 
the promoter activity (see Luc-SL13 and SL5), eventhough the shorter constructs still 
retained some transcriptional activity. The reduction in activity between Luc-SL23 
and Luc-SL13 indicated the existence of an activator or the core promoter within the 
first 240-bp DNA sequence upstream of the first methionine. The fact that reporter 
constructs containing the SCLIP promoter, at least up to 4.7 kb, were equally active in 
neural (PC12) and non-neural (RAT1) cells indicated that cell type-specific 
expression required some other region(s) of the gene. 
Identification of an NRS-like element (NRSSCLIP) in the downstream region of the 
promoter of the SCLIP gene 
Surprisingly, however, we noted a sequence at the translation starting point 
that was similar to the NRS sequence. Independent analysis by Curmi and his 
colleagues identified this element in the human SCLIP gene as SCLIP6 element (64). 
This sequence (NRSSCLIP) was completely conserved in the mouse and human genes 
(Fig. 2A), but the 3’-half of the sequence was destroyed in the SCLIP-luciferase 
reporter constructs used in the above promoter assays (see Fig. 2C). To assess 
whether the NRSSCLIP at the first-methionine codon of the SCLIP gene plays a role in 
the cell type-specific expression of the SCLIP promoter, we prepared two SCLIP 
promoter constructs, one containing (Luc-SL-N23) and one lacking (Luc-SL23) the 
NRSSCLIP, and examined their activity in cellular transfection experiments. The 
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Luc-SL-N23 SCLIP promoter construct was prepared by mutating the first five bases 
5' of the coding exon of the luciferase gene connected to the most active SCLIP 
promoter, Luc-SL23. PC12 and RAT1 cells were transfected with these constructs 
and tested for luciferase activity (Fig. 3A). The presence of NRSSCLIP led to a nearly 
100-fold reduction in SCLIP promoter activity in RAT1 cells, whereas in PC12 cells 
only a 4-fold reduction was observed (Fig. 3A). These data indicate that the NRSSCLIP 
plays a major role repressing SCLIP promoter activity preferentially in RAT1 cells, 
suggesting that NRSSCLIP is a cell-type specific or preferred transcriptional element.  
Position-dependent effect of NRSSCLIP 
Since the location of NRSSCLIP at the translational initiation site at the first 
exon was unusual compared with that of other currently known NRS elements, we 
questioned if NRSSCLIP may function when it was placed in other locations. To this 
end, we constructed 4 SCLIP promoter constructs containing NRSSCLIP at the 5' end of 
Luc-SL157 through Luc-SL23, respectively, and compared their activity with that of 
Luc-N-SL23 in cellular transfection experiments (Fig. 3B). As shown in Fig. 3 C, the 
silencing effect of NRSSCLIP increased as NRSSCLIP was moved approximately 
–1500-bp upstream or 300-bp downstream in the SCLIP promoter region. 
NRSSCLIP is regulated by NRSF 
To learn whether the NRSSCLIP interacts with a cellular protein, particularly 
with NRSF, we performed an electrophoretic mobility shift assay with nuclear 
extracts from HeLa cells and an oligonucleotide containing a single copy of the 
NRSSCLIP sequence as a probe. As a confirmation of a previous report (17), binding 
experiments using the SCG10 NRS as a probe detected a clear-cut DNA-NRSF 
complex with nuclear extracts prepared from HeLa cells (Fig. 4, lane 3), and a similar 
gel shift of DNA-NRSF complex was detected by using the SCLIP NRSSCLIP region 
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as a probe (Fig. 4, lane 4). The specificity of the gel shift obtained with the SCLIP 
probe was tested by competition experiments. Specific competition for the shift was 
obtained with a 10- to 100-fold molar excess of non-radioisotope-labeled SCLIP 
probe (Fig. 4, lanes 5-7). Similar competition was observed even with central GG/TT 
mutation, but was not observed with non-related sequences such as AP1 or SP1 (data 
not shown). Furthermore, when monoclonal anti-NRSF antibody (3B7) was included 
in the binding reaction, the band was supershifted, suggesting that NRSSCLIP was 
indeed bound by NRSF (Fig. 4, lanes 8, 9). The supershift was not observed with 
pre-immune serum.  
To demonstrate that the NRSSCLIP was a target for repression via NRSF, we 
performed cellular co-transfection experiments with NRSF expression constructs. 
First, a plasmid directing the expression of a dominant-negative form of NRSF 
protein (dn-NRSF), which contained the internal domain but not the two repression 
domains within the N- and C-terminal regions, was used to transfect PC12 or RAT1 
cells along with either Luc-SL23 or Luc-SL-N23 to examine whether the dn-NRSF 
could prevent repression of the SCLIP promoter activity. The dn-NRSF apparently 
released repression of Luc-SL-N23 in RAT1 cells but not in PC12 cells (Fig.5 A and 
B). Secondly, PC12 or RAT1 cells were co-transfected with Luc-SL23 or 
Luc-SL-N23 and a plasmid expressing the full-length NRSF protein (fl-NRSF) to 
determine whether ectopic expression of NRSF in cells that normally contain low 
levels of NRSF activity could reduce the activity from Luc-SL-N23. Expression of 
fl-NRSF in PC12 cells led to repression of the activity of Luc-SL-N23 but not in 
RAT1 cells (Fig. 5 A and B). Note that transfection experiments with Luc-SL23 
reporter that does not contain NRSSCLIP did not effect luciferase activity in any 
condition. These results reflect the fact that the cell type-specific transcriptional 
regulation of the SCLIP gene is under the influence of the NRSSCLIP via NRSF. 
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Discussion 
The present studies provide evidence that the neuron-specific expression of the 
SCLIP gene is regulated, at least in part, by NRSSCLIP located in the downstream 
region of the promoter of the SCLIP gene. The cell-selective silencing activity of 
NRSSCLIP became more apparent when the element was placed far upstream, e.g., over 
1.5 kb-upstream, in the promoter region. Interestingly, when the element was placed 
less than 1 kb from the core promoter, the neural-restrictive silencing activity, i. e., 
relative silencing in non-neuronal vs. neuronal cells, was reduced. This finding is 
similar to the data showing that the NRS present in the 2 subunit gene of the 
nicotinic acetylcholine receptor (nAChR) was position dependent, and further even 
functioned as a neural preferred enhancer when it was located very close to the TATA 
box (34).  
The reduction of silencing activity at promoter-proximal region could be due 
to steric hindrance of chromatin. The fact that NRSF/REST recruits mSin3  (40-42) 
and/or CoREST (45) suggests that NRS-dependent transcriptional repression involves 
chromatin modification through the recruitment of either histone deacetylase (HDAC) 
1/2 (40-42) or other classes of HDACs (43,47,48), respectively. NRS, therefore, 
seems to be more effective when it is located in the upstream of the promoter or in the 
first intron. Indeed, the most well-characterized NRSs, in sodium channel type II and 
SCG10 genes, were located in 1-kb and 1.5-kb upstream of each promoter; and other 
NRSs, in the brain-derived neurotrophic factor (BDNF) and the neuro-glial cell 
adhesion molecule L1/Ng-CAM, were found in the first intron (35-37). Since the 
transcriptional repression complex including NRSF/REST becomes a part of a large 
protein complex including the nucleosome remodeling and deacetylating (NRD, also 
named NURD, NuRD) complex (47 ,48), it seems to require some distance of 
DNA-looping in order to maintain an efficient silencing of the core promoter. 
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It seems obvious that NRSSCLIP is regulated by NRSF, as it was bound by or at 
least included in the complex containing NRSF (see Fig. 4) and its transcriptional 
activity was affected by the exogenously added active or inactive NRSF constructs 
(see Fig. 5). In non neuronal cells, such as RAT1 fibroblasts, exogenously introduced 
dn-NRSF apparently de-repressed NRSSCLIP-containing Luc-SL-N23 reporter activity 
(Fig. 5B); however, fl-NRSF did not affected the luciferase activity of the 
Luc-SL-N23 construct in RAT1 fibroblast, but did affect its activity in PC12 cells. 
These results suggest that the expression level of endogenous NRSF is saturated in 
RAT1, whereas in PC12 cells NRSF is not expressed, or limited, but some 
functionally defective alternatively spliced forms of NRSF, such as REST4 (31,37), is 
expressed.  
In this context, the activity of NRSSCLIP may not be efficient as that of other 
NRS elements thus far found in various neuron-specific genes. It may also be possible 
that NRSSCLIP functions in a species specific manner as the 5’ region of the NRS 
homology is diverged between the human and rodent sequences (see Fig. 2A). We 
have searched related DNA sequences in the current human genome database, but 
were unable to find any closely related to NRSSCLIP except other NRS-like sequences 
(N. Izumi and N. Mori, data not shown). Therefore, other cis-regulatory elements may 
contribute to the neuron-specific gene expression of the SCLIP gene.  
It was rather surprising to us to find little homology in promoter sequences of 
the three neuron-specific SCG10 family genes, i. e., SCLIP, RB3, and SCG10, even 
though the coding exons among these genes were highly homologous with each other 
in the human and rodent genomes. We initially anticipated that SCLIP and RB3 genes 
may share a similar promoter structure together with the presence of NRS for 
neuronal specificity; however, we were unable to find any NRS-related sequence in 
the promoter upstream (at least up to 3-kb) or downstream (at least up to 1-kb) of the 
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RB3 gene. A NRS-like element was identified in the 10kb downstream of the human 
RB3 gene by Curmi and his colleagues (64); however the sequence seemed quite 
diverged from the authentic NRS consensus (only 13 matches out of 21 residues). 
Since the gene expression profiles of these SCG10-related members are distinct but 
similar in the sense that they are neuron-specific and developmentally regulated (60), 
it is still possible there may be other important regulatory elements in the genes of 
SCG10, RB3, and SCLIP that should differentiate the promoters of these genes from 
the non-cell-specific constitutive promoter of the stathmin gene.  
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Figure legends 
Fig. 1. Genomic organization of the SCLIP gene and its comparison to 
other members of the SCG10 family. A) Genomic organization of the mouse 
and human SCLIP genes. The white and black boxes indicate non-coding and 
coding regions, respectively. Exon numbers 1-5 of mouse and human SCLIP 
genes are given. B) The exon-intron boundaries were determined by 
comparing mouse genomic and cDNA sequences. Intron size and the 
donor-acceptor splice sites of the mouse SCLIP gene are shown. Intron 
sequences are shown in lower case, and the donor and acceptor sites are 
underlined. C) Comparison of the size and intron-exon structures of the mouse 
SCG10-related gene family. The genomic organization of the mouse SCLIP 
and RB3 genes as well as that of the mouse SCG10 and stathmin ones is 
presented for comparison. Interruption in the first intron of SCG10 and SCLIP 
genes indicates that the regions have not been fully determined for actual 
distance. The closed triangle in the promoter region of the SCG10 gene 
indicates the position of NRS, and the open triangle on the SCLIP gene 
denotes the position of the NRS-like sequence, NRSSCLIP. D) Exon-domain 
structure relationship. The mouse SCLIP, RB3, SCG10, and stathmin genes 
are aligned with space introduced between exons: conserved amino acids are 
indicated by asterisks. 
Fig. 2. Identification of NRSSCLIP in the promoter of mouse and human 
SCLIP genes and its effect on cell-selective gene transcription. A) 
Comparison of the sequences at the 5' end of the mouse (m) and human (h) 
SCLIP genes. A putative binding site for NRSF is boxed, Sp1 and TFI sites are 
underlined, and conserved nucleotides are marked by asterisks. First intron 
sequences are indicated by lower case letters, and the intron donor sequences 
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are underlined. Transcriptional start sites (P1-P6) as determined in panel B are 
marked with closed circles; note that P1 is the major transcriptional initiation 
site. A block arrow represents the primer used in the primer extention assay 
experiment (see panel B). Endpoints of the deletion constructs used in panel C 
are indicated above the sequence. B) Determination of transcription initiation 
sites of the mouse SCLIP gene by primary extension assay. Primer extension 
products, P1 through P6, are marked in lane 1 that was performed in the 
presence of RNA template. No product was obtained in the reaction without 
RNA template, as shown in lane 2. Size markers are 32P-labelled HinfI-digest 
of X174 DNA. C) Activity of SCLIP promoter constructs in cellular 
transfection experiments using PC12 and RAT1 cells. The relative luciferase 
activities of SCLIP constructs are expressed as a percentage of the SV40 
promoter activity of the pGL3 control vector. The values for the pGL3 control 
and pGL3 basic were set at 100 and 0%, respectively. The data shown are the 
means ±S.E. of three separate transfection experiments. D) Comparison of 
NRSSCLIP with the NRS consensus and NRSSCG10 and the boundary sequence 
generated in the SCLIP promoter-driven luciferase reporter gene constructs. 
Note that the 3’ half of the SCLIP/Luciferase plasmid is diverged extensively 
from the authentic NRS consensus sequence. 
Fig. 3. Characterization of NRSSCLIP with respect to cell-type selective 
transcriptional repression. A) Activity of SCLIP promoter constructs with or 
without NRS-like sequence (NRSSCLIP) in cellular transfection experiments 
using PC12 and RAT1 cells. The relative luciferase activity of SCLIP 
constructs is expressed as a percentage of SV40 promoter activity produced by 
the pGL3 control vector. The values for the pGL3 control and pGL3 basic 
were set at 100 and 0% as in Fig.2. The data shown are the means ±S.E. of 
three separate experiments. B) NRSSCLIP mediates transcriptional repression of 
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the SCLIP promoter construct position dependently in cellular transfection 
experiments using PC12 and RAT1 cells. The relative luciferase activity of 
NRSSCLIP-containing SCLIP constructs is expressed as a percentage of the 
activity of NRSSCLIP-lacking SCLIP constructs, the values of which were set at 
100%. The data shown are the means±S.E. of three separate experiments. C) 
Suppression by NRSSCLIP-containing SCLIP promoter constructs is stronger in 
RAT1 cells than in PC12 cells. Fold-suppression was calculated for each 
construct in each cell line as the reciprocal of the activity relative to that of the 
NRSSCLIP-lacking SCLIP promoter construct. The ratio of this value for PC12 
and RAT1 cells was then calculated. 
Fig. 4. Identification of an NRSSCLIP-binding factor in HeLa nuclear 
extracts. Lanes 1 and 2 contained probe only; and lanes 3 and 4, probe with 
the nuclear extract. Lanes 5, 6, and 7 included either a 10-, 50- or 100-fold 
molar excess of unlabeled probe of NRSSCLIP. Lane 3 shows the NRS-NRSF 
complex formed with the SCG10 probe, and lane 4, a similar complex with the 
SCLIP probe. The arrow indicates that the complex could be competed with 
competitor fragments based on the NRSSCLIP sequence. Lanes 8 and 9 are 
super-shift experiment using NRSF-specific monoclonal antibody, 3B7. 
Fig. 5. Effects of exogeneously added full-length (fl) or dominant negative 
(dn) NRSF on the NRSSCLIP-bearing promoter activity. (A) Relative 
luciferase activities of extracts of PC12 cells transfected with reporter plasmid 
with or without NRSF plasmids. Lane 1, reporter (either Luc-SL23 or 
Luc-SL-N23) only; lane 2, reporter with fl-NRSF; lane 3, reporter with 
dn-NRSF. (B) Relative luciferase activities of extracts of Rat1 cells transfected 
with reporter with or without NRSF plasmids. Lane 1, reporter only; lane 2, 
reporter with fl-NRSF; lane 3, reporter with dn-NRSF. 
Fig. 1
           
Intron              Donor              Accepter             Size (bp)
  1     ACCGTATCTGgtagggctcg----------acatccacagCCTACAAGGA   2237+
  2     CAGTATGGAGgtgagtgtat----------tgtcctacagATATGGAAGT    250
  3     GCGGAGGAAGgcaaggactc----------ctctgtgcagACTCAGGAGG   1314
  4     GCGCGAGAAGgtaggcacgc----------gtcttcacagGAGCTGCACG    391
B
human SCLIP
8928 bp 283 bp 1457 bp 915 bp
mouse SCLIP
> 2237 bp 250 bp 391 bp1314 bp






exon 5exon 1 exon 4exon 3exon 2
           [exon 1][-------------exon 2-------------][---------------------------exon 3--------------------------]
SCG10       MAKTAM  AYKEKMKELSMLSLICSCFYPEPRNINIYTYD  DMEVKQINKRASGQAFELILKPPSPISEAPRTLAS--KKKDLSLEEIQKKLEAAEERRK   
SCLIP       MASTVS  AYKEKMKELSVLSLICSCFYSQPHPNTIYQYG  DMEVKQLDKRASGQSFEVILKSPSDLSPESPVLSSPPKRKDASLEELQKRLEAAEERRK   
RB3           MTLA  AYKEKMKELPLVSLFCSCFLSDPLNKSSYKYE  DMEVIELNKCTSGQSFEVILKPPSFDGVPEFNASLP-RRRDPSLEEIQKKLEAAEERRK   
Stathmin                                        MASS  DIQVKELEKRASGQAFELILSPRSKESVPDFPLSPP-KKKDLSLEEIQKKLEAAEERRK   
consensus      *    *********   ** ****   *           *  *  * *  *** ** **   *                * **** ** *********     
           [----------------------------exon 4------------------------------][---------exon 5--------]
SCG10       SQEAQVLKQLAEKREHEREVLQKALEENNNFSKMAEEKLILKMEQIKENREANLAAIIERLQEK  ERHAAEVRRNKELQVELSG  
SCLIP       TQEAQVLKQLAERREHEREVLHKALEENNNFSRLAEEKLNYKMELSKEIREAHLAALRERLREK  ELHAAEVRRNKEQREEMSG
RB3         YQEAELLKHLAEKREHEREVIQKAIEENNNFIKMAKEKLAQKMESNKENREAHLAAMLERLQEK  DKHAEEVRKNKELKEEASR
Stathmin    SHEAEVLKQLAEKREHEKEVLQKAIEENNNFSKMAEEKLTHKMEANKENREAQMAAKLERLREK  DKHVEEVRKNKESKDPADETEAD   
consensus     **  ** *** **** **  ** ******   * ***  ***  ** ***  **  *** **    *  *** ***
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                                                                   P6
                                                                       TFII-I
          m   CTTGTCTTTGATAGTTGCTGCCAGCGTTTGTTCGTCCACTGTCTGTCGGATCTGTCTCTC   -241
          h   -CTCTCTCTCTTCCTCCCTCCCTTCCTCCCTCCCTCCTTCCCCCGCCCCCGCAGTCTCTC   -242
                * *** *  *  *  ** **  * *   * * ***     * * *    * *******
               P5
                  .Luc-SL23                       SP1
          m   TCTCCCTCT-TCTCTCTCCTTCT-CCCTCCCTCCCGCCCTTCCTCTCTCCTTTCCTCTCT   -183
          h   TCTCTCTCTCTCTCCTTCCCCCAACCCTCCCTCCCTCCTCCCCCCGCTCCTT-CCCCCAA   -183
              **** **** ****  ***  *  *********** **   ** * ****** ** *   
                                                                 .Luc-SL13
          m   TTCTTCCTCTCCCCTCCCCTTCCTTCCACCCCCACTC-CTCCATCCATCCCTCGCTCCCT   -124
          h   CCCTCTCTCTCTCTCCCTCTGTCTCCCTCCCTCTCTCTCTCCCGCCGCGCCCGCCTCCCG   -123
                **  ***** *  ** **  ** ** *** * *** ****  **   **   ***** 
                            P4                                P3    P2
                                SP1
          m   CCCCCTCTTGCCGCGCCCGCCCTTCCTCCCTCCCCTCCACAGCATTGCAGCATTCGCAGA    -64
          h   CCCGCCCTCGCTCCCTCCACTCCTCTCCCCTCCCCTCCCCGGCACTGCAGCACCAGCCGT    -63
              *** * ** **  *  ** * * **  *********** * *** *******   ** * 
               P1
                      .Luc-SL5
          m   CTGCAGCTCCCAGACACCGCCCGCATCCCTCCGGCCTCCGAAGCCCCAGCCGCCGCCAGC     -4
          h   CTGCAGCT-CCGGCCGCCACTTGCGCCTCTCCAGCCTCCGCAGGCCCAACCGCCGCCAGC     -4
              ******** ** * * ** *  **  * **** ******* ** **** ***********
                  M  A  S  T  V  S
          m   ACCATGGCCAGCACCGTATCTGgtagggctcg       
          h   ACCATGGCCAGCACCATTTCCGgtaggctccg
              *************** * ** ******   **
                    MetAlaSerThr
SCLIP: GCCAG ACCATGGC G ACC
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